Clostridium difficile pp 167-175 | Cite as
Induction and Purification of C. difficile Phage Tail-Like Particles
- 2 Citations
- 10 Mentions
- 2.1k Downloads
Abstract
Due to the inherent limitations of conventional antibiotics for the treatment of C. difficile infection (CDI), there is a growing interest in the development of alternative treatment strategies. Both bacteriophages and R-type bacteriocins, also known as phage tail-like particles (PTLPs), show promise as potential antibacterial alternatives for treating CDI. Similar to bacteriophages, but lacking a viral capsid and genome, PTLPs remain capable of killing target bacteria. Here we describe our experience in the induction and purification of C. difficile PTLPs. These methods have been optimized to allow production of concentrated, non-contractile, and non-aggregated samples for both sensitivity testing and structural electron microscopy studies.
Key words
Clostridium difficile Phage tail-like particles Induction Purification MicroscopyReferences
- 1.McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97:1769–1775CrossRefPubMedGoogle Scholar
- 2.Surawicz CM (2013) Infection: treating recurrent C. difficile infection-the challenge continues. Nat Rev Gastroenterol Hepatol 10(1):10–11CrossRefPubMedGoogle Scholar
- 3.Hargreaves KR, Clokie MR (2014) Clostridium difficile phages: still difficult? Front Microbiol 28(5):184Google Scholar
- 4.Nakonieczna A, Cooper CJ, Gryko R. (2015) Bacteriophages and bacteriophage derived endolysins as potential therapeutics to combat gram positive spore forming bacteria. J Appl Microbiol. June 24 [Epub]Google Scholar
- 5.Michel-Briand Y, Baysse C (2002) The pyocins of Pseudomonas aeruginosa. Biochimie 84:449–510CrossRefGoogle Scholar
- 6.Fortier LC, Moineau S (2007) Morphological and genetic diversity of temperate phages in Clostridium difficile. Appl Environ Microbiol 73:7358–7366CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Nale JY, Shan J, Hickenbotham PT, Fawley WN, Wilcox MH, Clokie MR (2012) Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains. PLoS One 7:e37263CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Gebhart D, Williams SR, Bishop-Lilly KA, Govoni GR, Willner KM, Butani A et al (2012) Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile. J Bacteriol 194:6240–6247CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Sangster W, Hegarty JP, Stewart DB Sr (2015) Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics. Surgery 157(1):96–103CrossRefPubMedGoogle Scholar
- 10.Gebhart D, Lok S, Clare S, Tomas M, Stares M, Scholl D, Donskey CJ, Lawley TD, Govoni GR (2015) A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. MBio 6(2):e02368-14CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Ge P, Scholl D, Leiman PG, Yu X, Miller JF, Zhou ZH (2015) Atomic structures of a bactericidal contractile nanotube in its pre- and post-contraction states. Nat Struct Mol Biol 22(5):377–382PubMedPubMedCentralGoogle Scholar
- 12.Goh S, Riley TV, Chang BJ (2005) Isolation and characterization of temperate bacteriophages of Clostridium difficile. Appl Environ Microbiol 71(2):1079–1083CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Sekulovic O, Garneau JR, Néron A, Fortier LC (2014) Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. Appl Environ Microbiol 80(8):2555–2556CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Meessen-Pinard M, Sekulovic O, Fortier LC (2012) Evidence of in vivo prophage induction during Clostridium difficile infection. Appl Environ Microbiol 78(21):7662–7670CrossRefPubMedPubMedCentralGoogle Scholar